World's Best Scientists 2026 revealed!
Marco Rovaris

Marco Rovaris

D-Index & Metrics

Medicine

D-Index
80
Citations
21107
World Ranking
17218
National Ranking
695

Marco Rovaris publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Marco Rovaris sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 465 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Marco Rovaris D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Marco Rovaris sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Marco Rovaris is affiliated with the University of Milan in Italy. Their research primarily focuses on the field of Medicine, with a particular emphasis on Pathology and Forensic Medicine, Psychiatry and Mental Health, Oncology, Physiology, and Neurology. Within these areas, their work extensively covers Multiple Sclerosis Research Studies, along with research on Polyomavirus and related diseases, Rheumatoid Arthritis Research and Therapies, Cerebral Palsy and Movement Disorders, Voice and Speech Disorders, Acute Lymphoblastic Leukemia research, and Autoimmune and Inflammatory Disorders Research.

Rovaris has published numerous papers in various scientific journals. Some recent publications include:

  • Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies, 2021, Therapeutic Advances in Neurological Disorders
  • Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis, 2021, JAMA Neurology
  • Social Cognition Training for Enhancing Affective and Cognitive Theory of Mind in Schizophrenia: A Systematic Review and a Meta-Analysis, 2020, The Journal of Psychology
  • Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis, 2020, Journal of Neurology Neurosurgery & Psychiatry
  • Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study, 2023, International Journal of Molecular Sciences

Their frequent co-authors include Francesco Patti, Davide Cattaneo, Eleonora Cocco, Massimo Filippi, and Paola Cavalla. These collaborations suggest a strong network within the field of neurological and medical research.

Marco Rovaris has contributed to publications in various venues, often publishing in:

  • Multiple Sclerosis and Related Disorders
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal of Neurology
  • International Journal of Molecular Sciences
  • JAMA Neurology

Their academic output reveals a particular focus on studying multiple sclerosis, including treatment strategies, disability outcomes, and biomarker research. The interdisciplinary scope also covers cognitive and affective aspects in related psychiatric conditions, reflecting a broad engagement with neurological and immunological disorders.

Best Publications

  • Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.

    Giancarlo Comi;Massimo Filippi;Frederik Barkhof;Luca Durelli

  • Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

    Massimo Filippi;M. Bozzali;M. Rovaris;O. Gonen

  • MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.

    Josephine K Swanton;Alex Rovira;Mar Tintore;Daniel R Altmann;Daniel R Altmann

  • Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

    N. De Stefano;A. Giorgio;M. Battaglini;M. Rovaris

  • MRI criteria for MS in patients with clinically isolated syndromes

    X. Montalban;M. Tintore;J. Swanton;F. Barkhof

  • Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

    G Giancarlo Comi;A. Pulizzi;Marco Rovaris;O. Abramsky

  • Secondary progressive multiple sclerosis: current knowledge and future challenges

    Marco Rovaris;Christian Confavreux;Roberto Furlan;Ludwig Kappos

  • Diffusion MRI in multiple sclerosis

    M. Rovaris;A. Gass;R. Bammer;S. J. Hickman

  • Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis

    M. Rovaris;Massimo Filippi;M. Falautano;L. Minicucci

  • Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial.

    Massimo Filippi;Marco Rovaris;Matilde Inglese;Frederik Barkhof

  • MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

    Arnaud Charil;Tarek A Yousry;Marco Rovaris;Frederik Barkhof

  • Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.

    Marco Rovaris;Giuseppe Iannucci;Monica Falautano;Francesca Possa

  • Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

    M Filippi;C Tortorella;M Rovaris;M Bozzali

  • Mitoxantrone for multiple sclerosis.

    Filippo Martinelli Boneschi;Laura Vacchi;Marco Rovaris;Ruggero Capra

  • Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype.

    Elisabetta Pagani;Maria A. Rocca;Antonio Gallo;Marco Rovaris

  • Nocturnal sleep study in multiple sclerosis: Correlations with clinical and brain magnetic resonance imaging findings

    Luigi Ferini-Strambi;Massimo Filippi;Vittorio Martinelli;Alessandro Oldani

  • Primary and transitional progressive MS: a clinical and MRI cross-sectional study.

    V.L. Stevenson;D.H. Miller;M. Rovaris;F. Barkhof

  • Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications.

    Marco Rovaris;Giancarlo Comi;Maria A. Rocca;Jerry S. Wolinsky

  • Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study.

    Marco Rovaris;Marco Bozzali;Giuseppe Iannucci;Angelo Ghezzi

  • Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation.

    Giuseppe Iannucci;Carla Tortorella;Marco Rovaris;Maria Pia Sormani

Frequent Co-Authors

Massimo Filippi
Massimo Filippi Vita-Salute San Raffaele University
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Frederik Barkhof
Frederik Barkhof University College London
Maria A. Rocca
Maria A. Rocca Vita-Salute San Raffaele University
Maria Pia Sormani
Maria Pia Sormani University of Genoa
Mario Clerici
Mario Clerici University of Milan
Vittorio Martinelli
Vittorio Martinelli Vita-Salute San Raffaele University
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Chris H. Polman
Chris H. Polman VU University Medical Center
Marina Saresella
Marina Saresella MRC Laboratory of Molecular Biology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn’t always mean following the traditional path to an MD. There are a variety of online programs in related fields that open the door to rewarding healthcare roles. For instance, aspiring pharmacists can consider online pharmacy schools that offer flexible options for advanced pharmacy training.

If you’re interested in the intersection of healthcare and technology, rhit programs online provide essential skills for managing medical records and health data. These programs can lead to fast-growing career options outside of direct patient care.

For those seeking entry into the medical field with a shorter study timeline, online medical billing and coding courses are a practical choice. These programs focus on the administrative side of healthcare.

Nurses who wish to advance their careers can look into the cheapest online fnp program options. Becoming a Family Nurse Practitioner online allows for flexibility and the ability to continue working while earning a degree.

Best Scientists Citing Marco Rovaris

Trending Scientists

Recently Published Articles